• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Pain Patch Companies

    ID: MRFR/HC/7097-HCR
    90 Pages
    Kinjoll Dey
    September 2025

    At the forefront of pain management, Pain Patch companies specialize in transdermal patches delivering controlled medication. Their innovative patches offer sustained relief for chronic pain conditions, providing patients with a convenient and non-invasive approach to manage discomfort and improve overall quality of life.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Top Industry Leaders in the Pain Patch Market

    Pain Patch Key Companies

     


    Latest Pain Patch Companies Update:

    ACADIA Pharmaceuticals: Acquired CerSci Therapeutics Inc. in October 2023, gaining access to promising non-opioid pain medication candidates for patch delivery.


    Grünenthal GmbH: Completed Phase 3 trials for Qutenza (lidocaine patch) for diabetic peripheral neuropathy, marking a potential non-opioid option for this prevalent condition.


    Zogenix: Successfully tested ZX004, a novel non-opioid patch for neuropathic pain, in a Phase 2 trial, showcasing its potential for future development.


    Purdue Pharma L.P.: Filed for bankruptcy in 2019 amidst the opioid crisis and ongoing lawsuits, impacting the distribution of OxyContin patches.


    List of Pain Patch Key companies in the market

    • LTS Lohmann Therapie-Systeme AG (Germany)

    • (US)

    • Mylan N.V.(US)

    • Pfizer, Inc. (US)

    • Teva Pharmaceutical Company (Allergan Plc (Actavis)) (Israel)

    • Endo Pharmaceuticals Inc (Israel)

    • Hisamitsu America, Inc. (America)

    • Johnson & Johnson (US)

    • Teikoku Seiyaku Co., Ltd (Japan)

    • Sanofi (France)

    • NICHIBAN Co (Japan)

    • The Mentholatum Company (US)